at Nasdaq.com (Mon, 11:42AM)
Celldex (CLDX +5.2%) gains today as the company says its final results from its Phase 1 study of CDX-301 supports the initiation of a pilot study in hematopoietic stem cell transplantation later this year.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 19, 2015)
at Zacks.com (Dec 5, 2014)
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blogat Zacks.com (Nov 19, 2014)
at Zacks.com (Nov 18, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs